• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

38例类脂质渐进性坏死患者血清脂蛋白(a)水平及皮肤表达分析。

Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy.

作者信息

Espinel Danielle P G S, Di Giacomo Thais B, Pincelli Thais P, Pereira Naiura V, Sotto Miriam N, Kirsner Robert S, Criado Paulo R

机构信息

Dermatology Department of Hospital das Clínicas, University of Sao Paulo Medical School, São Paulo, Brazil.

Laboratory of Investigative Dermatology and Immunodeficiencies, University of Sao Paulo Medical School, São Paulo, Brazil.

出版信息

J Cutan Pathol. 2017 Dec;44(12):1033-1037. doi: 10.1111/cup.13043. Epub 2017 Oct 13.

DOI:10.1111/cup.13043
PMID:28901563
Abstract

BACKGROUND

Coagulation disorders contribute to the development of livedoid vasculopathy (LV). Elevated plasma levels of lipoprotein(a) [Lp(a)] are an independent risk factor for the development of cardiovascular disease and associated with hypercoagulable states. Increased serum Lp(a) levels have been reported in patients with LV and may have an important role in the pathogenesis of LV.

OBJECTIVES

To investigate Lp(a) expression in skin lesions and circulating serum Lp(a) levels in patients with LV.

METHODS

Skin biopsy samples from 38 patients (27 women and 11 men) with active lesions diagnosed as LV and 9 samples of normal skin (5 women and 4 men) from control patients without LV were evaluated for skin expression of Lp(a) by immunohistochemistry. Plasma levels of Lp(a) were analyzed by immunoturbidimetry.

RESULTS

We found that lesional skin in patients with LV expressed 10-fold higher Lp(a) immunostaining than controls. High plasma levels of Lp(a) were observed in LV patients. We did not find a correlation (P = .02) between expression of Lp(a) in the skin and plasma levels of Lp(a) in patients with LV.

CONCLUSIONS

Increased Lp(a) expression in lesional skin of LV patients suggests the role of Lp(a) in the thrombo-occlusive vasculopathy observed in this disease.

摘要

背景

凝血功能障碍促使类脂质渐进性坏死性血管病(LV)的发生。脂蛋白(a)[Lp(a)]血浆水平升高是心血管疾病发生的独立危险因素,并与高凝状态相关。LV患者中已报道血清Lp(a)水平升高,其可能在LV的发病机制中起重要作用。

目的

研究LV患者皮肤病变中Lp(a)的表达及循环血清Lp(a)水平。

方法

对38例(27例女性和11例男性)诊断为LV且有活动性病变的患者的皮肤活检样本,以及9例来自无LV的对照患者的正常皮肤样本(5例女性和4例男性)进行免疫组织化学评估,以检测Lp(a)的皮肤表达。采用免疫比浊法分析血浆Lp(a)水平。

结果

我们发现LV患者的病变皮肤Lp(a)免疫染色比对照组高10倍。LV患者中观察到血浆Lp(a)水平较高。我们未发现LV患者皮肤中Lp(a)的表达与血浆Lp(a)水平之间存在相关性(P = 0.02)。

结论

LV患者病变皮肤中Lp(a)表达增加表明Lp(a)在该疾病中观察到的血栓闭塞性血管病中起作用。

相似文献

1
Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy.38例类脂质渐进性坏死患者血清脂蛋白(a)水平及皮肤表达分析。
J Cutan Pathol. 2017 Dec;44(12):1033-1037. doi: 10.1111/cup.13043. Epub 2017 Oct 13.
2
Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol.
Dermatol Ther. 2015 Jul-Aug;28(4):248-53. doi: 10.1111/dth.12225. Epub 2015 Mar 30.
3
Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?脂蛋白(a)与类脂质渐进性坏死性血管病:一种新的易栓因素?
Med Hypotheses. 2015 Nov;85(5):670-4. doi: 10.1016/j.mehy.2015.08.009. Epub 2015 Aug 29.
4
Case of livedoid vasculopathy with extensive dermal capillary thrombi.皮肤血管病伴广泛真皮毛细血管血栓形成 1 例。
J Dermatol. 2010 Jan;37(1):94-7. doi: 10.1111/j.1346-8138.2009.00753.x.
5
Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions.
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12255.
6
Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.镰状细胞病患者出现的萎缩性血管病变
Am J Dermatopathol. 2018 Sep;40(9):682-685. doi: 10.1097/DAD.0000000000001133.
7
Livedoid vasculopathy secondary to high levels of lipoprotein(a).继发于高水平脂蛋白(a)的类脂质渐进性坏死性血管病
Br J Dermatol. 2011 May;164(5):1111-3. doi: 10.1111/j.1365-2133.2011.10216.x.
8
Livedoid vasculopathy presenting with leg ulcers.以腿部溃疡为表现的萎缩性硬化性苔藓样血管病。
Rheumatology (Oxford). 2019 Nov 1;58(11):2076. doi: 10.1093/rheumatology/kez126.
9
Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy.淤血性血管病变中的血管内皮功能障碍、血栓形成倾向和甲襞毛细血管镜特征。
Microvasc Res. 2023 Nov;150:104591. doi: 10.1016/j.mvr.2023.104591. Epub 2023 Aug 4.
10
Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.新型低剂量口服抗凝剂治疗顽固性类脂质渐进性坏死性血管病的疗效
BMJ Case Rep. 2017 Jul 24;2017:bcr-2017-219943. doi: 10.1136/bcr-2017-219943.

引用本文的文献

1
Livedoid vasculopathy: A review with focus on terminology and pathogenesis.皮肤白细胞碎裂性血管病:术语和发病机制综述。
Vasc Med. 2022 Dec;27(6):593-603. doi: 10.1177/1358863X221130380. Epub 2022 Oct 26.
2
Livedoid vasculopathy - A diagnostic and therapeutic challenge.萎缩性硬化性苔藓样血管病——诊断与治疗的挑战。
Front Med (Lausanne). 2022 Oct 3;9:1012178. doi: 10.3389/fmed.2022.1012178. eCollection 2022.
3
Cutaneous Manifestations of Coronavirus Disease 2019: Skin Narratives and Dialogues.2019冠状病毒病的皮肤表现:皮肤故事与探讨
J Clin Aesthet Dermatol. 2022 May;15(5):E77-E81.
4
Skin manifestations of COVID-19: A worldwide review.新型冠状病毒肺炎的皮肤表现:一项全球综述。
JAAD Int. 2021 Mar;2:119-133. doi: 10.1016/j.jdin.2020.12.003. Epub 2020 Dec 16.
5
Lessons from dermatology about inflammatory responses in Covid-19.皮肤科在新冠病毒炎症反应中的启示。
Rev Med Virol. 2020 Sep;30(5):e2130. doi: 10.1002/rmv.2130. Epub 2020 Jul 12.